Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Indication: Allergic rhinitis Age: Adults |
Dose: Nasal spray – 2 sprays (100 mcg) in each nostril Frequency: once daily Note: Preferably in the morning. |
|
Indication: Allergic rhinitis Age: Adults Condition: In some cases |
Dose: Nasal spray – 2 sprays into each nostril Frequency: twice daily Note: Not exceeding 4 sprays. |
| Clinical Information | Administration Information |
|---|---|
|
Indication: Allergic rhinitis Age: Children over 12 years |
Dose: Nasal spray – 2 sprays (100 mcg) in each nostril Frequency: once daily Note: preferably in the morning; in some cases 2 sprays into each nostril twice daily, not exceeding 4 sprays |
|
Indication: Allergic rhinitis Age: Children under 12 years (4 - 11 years) |
Dose: Nasal spray – 1 spray (50 mcg) in each nostril Frequency: once daily Note: maximum total daily dosage should not exceed 4 sprays |
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 inhibitors (e.g. ritonavir)
|
May lead to increased plasma concentrations
|
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Details coming soon
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.